Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**6-Chloro‐2‐(2‐hydroxy‐biphenyl‐3‐yl)‐1H‐indole‐5‐carboxamidine** is a synthetic small molecule belonging to the class of 2-phenyindoles. It is primarily used as a research tool and has not been approved for clinical use in any country. The compound has been studied for its ability to interact with protein targets, but no specific therapeutic indication or mechanism of action in humans is established. Its structure features an indole core substituted with a chloro group and a biphenylyl moiety bearing a hydroxy group and carboxamidine functionality[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 6-chloro-2-(2-hydroxy-biphenyl-3-yl)-1h-indole-5-carboxamidine.